Immune responses to tuberculosis in developing countries: implications for new vaccines
@article{Rook2005ImmuneRT, title={Immune responses to tuberculosis in developing countries: implications for new vaccines}, author={G. Rook and K. Dheda and Alimuddin Zumla}, journal={Nature Reviews Immunology}, year={2005}, volume={5}, pages={661-667} }
Tuberculosis is out of control in developing countries, where it is killing millions of people every year. In these areas, the present vaccine — Mycobacterium bovis bacillus Calmette–Guérin (BCG) — is failing. Progressive tuberculosis occurs because the potentially protective T helper 1 (TH1)-cell response is converted to an immunopathological response that fails to eliminate the bacteria. Here, we discuss the data indicating that the problem in developing countries is not a lack of adequate… CONTINUE READING
182 Citations
Immune protection against tuberculosis--when is immunotherapy preferable to vaccination?
- Medicine
- Tuberculosis
- 2011
- 16
Effector and Regulatory CD4 T Cells During Mycobacterium tuberculosis Infection
- Biology
- 2010
- Highly Influenced
- PDF
Challenges and solutions for a rational vaccine design for TB-endemic regions
- Medicine
- Critical reviews in microbiology
- 2015
- 11
The quest for a new vaccine against tuberculosis.
- Medicine
- Journal of infection in developing countries
- 2009
- 43
- PDF
Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not.
- Biology, Medicine
- Tuberculosis
- 2006
- 41
Lessons for tuberculosis vaccines from respiratory virus infection
- Medicine
- Expert review of vaccines
- 2008
- 8
Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis*
- Biology, Medicine
- The Journal of Biological Chemistry
- 2014
- 31
- PDF
References
SHOWING 1-10 OF 106 REFERENCES
Do successful tuberculosis vaccines need to be immunoregulatory rather than merely Th1-boosting?
- Medicine
- Vaccine
- 2005
- 81
- PDF
The success and failure of BCG — implications for a novel tuberculosis vaccine
- Medicine, Biology
- Nature Reviews Microbiology
- 2005
- 642
Variation in protection by BCG: implications of and for heterologous immunity
- Medicine
- The Lancet
- 1995
- 1,287
IL-10-producing T cells suppress immune responses in anergic tuberculosis patients.
- Biology, Medicine
- The Journal of clinical investigation
- 2000
- 419
- PDF
A New Vaccine against Tuberculosis Affords Greater Survival after Challenge than the Current Vaccine in the Guinea Pig Model of Pulmonary Tuberculosis
- Biology, Medicine
- Infection and Immunity
- 2003
- 209
- PDF
Healthy Individuals That Control a Latent Infection with Mycobacterium tuberculosis Express High Levels of Th1 Cytokines and the IL-4 Antagonist IL-4δ21
- Medicine, Biology
- The Journal of Immunology
- 2004
- 188
- PDF
Selecting the components for a safe and efficient tuberculosis subunit vaccine--recent progress and post-genomic insights.
- Biology, Medicine
- Current pharmaceutical biotechnology
- 2003
- 12
Mycobacterial Antigens Exacerbate Disease Manifestations in Mycobacterium tuberculosis-Infected Mice
- Biology, Medicine
- Infection and Immunity
- 2002
- 101
- PDF